Stay updated on REGN2810 Combo vs Pembrolizumab in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the REGN2810 Combo vs Pembrolizumab in Lung Cancer Clinical Trial page.

Latest updates to the REGN2810 Combo vs Pembrolizumab in Lung Cancer Clinical Trial page
- CheckyesterdayChange DetectedA footer revision tag was updated from v3.4.0 to v3.4.1; no changes to the main study details or user-facing features were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check8 days agoChange DetectedThese changes are minor UI and metadata updates: the glossary toggle label, capitalization tweaks (e.g., 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'), and a new 'Revision: v3.4.0' tag with corresponding deletions of the old wording. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4 on the page. No other study content or functionality changes are evident.SummaryDifference0.1%

- Check44 days agoChange DetectedAdded a dedicated Locations section with Florida listed as a location, and removed the Florida Locations reference. The revision note was updated from v3.3.2 to v3.3.3, and the HHS Vulnerability Disclosure link was removed.SummaryDifference0.2%

- Check72 days agoChange DetectedRevision label updated from v3.2.0 to v3.3.2 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check79 days agoChange DetectedThe funding-status warning about government delays has been removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to REGN2810 Combo vs Pembrolizumab in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the REGN2810 Combo vs Pembrolizumab in Lung Cancer Clinical Trial page.